These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16626903)

  • 21. Assessment of non-linear combination effect terms for drug-drug interactions.
    Koch G; Schropp J; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):461-79. PubMed ID: 27638639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding synergy.
    Geary N
    Am J Physiol Endocrinol Metab; 2013 Feb; 304(3):E237-53. PubMed ID: 23211518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel flexible approach for evaluating fixed ratio mixtures of full and partial agonists.
    Gennings C; Carter WH; Carney EW; Charles GD; Gollapudi BB; Carchman RA
    Toxicol Sci; 2004 Jul; 80(1):134-50. PubMed ID: 15084752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A generalized response surface model with varying relative potency for assessing drug interaction.
    Kong M; Lee JJ
    Biometrics; 2006 Dec; 62(4):986-95. PubMed ID: 17156272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental design and interaction analysis of combination studies of drugs with log-linear dose responses.
    Fang HB; Ross DD; Sausville E; Tan M
    Stat Med; 2008 Jul; 27(16):3071-83. PubMed ID: 18186545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?
    Jonker DM; Voskuyl RA; Danhof M
    Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the Effect of Mycotoxin Combinations: Which Mathematical Model Is (the Most) Appropriate?
    Kifer D; Jakšić D; Šegvić Klarić M
    Toxins (Basel); 2020 Feb; 12(3):. PubMed ID: 32121330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling of microbial population responses to time-periodic concentrations of antimicrobial agents.
    Nikolaou M; Schilling AN; Vo G; Chang KT; Tam VH
    Ann Biomed Eng; 2007 Aug; 35(8):1458-70. PubMed ID: 17431788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
    Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
    Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Methods for Quantifying Drug Synergism.
    Ma J; Motsinger-Reif A
    Proteom Bioinform; 2019 Jul; 1(2):43-48. PubMed ID: 32043089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
    Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
    Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug combinations--concepts and terminology.
    Unkelbach HD; Wolf T
    Arzneimittelforschung; 1984; 34(9):935-8. PubMed ID: 6542372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions.
    Boobis A; Watelet JB; Whomsley R; Benedetti MS; Demoly P; Tipton K
    Drug Metab Rev; 2009; 41(3):486-527. PubMed ID: 19601724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additivity and Interactions in Ecotoxicity of Pollutant Mixtures: Some Patterns, Conclusions, and Open Questions.
    Rodea-Palomares I; González-Pleiter M; Martín-Betancor K; Rosal R; Fernández-Piñas F
    Toxics; 2015 Sep; 3(4):342-369. PubMed ID: 29051468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose addition and the isobole method as approaches for predicting the cumulative effect of non-interacting chemicals: a critical evaluation.
    Bosgra S; van Eijkeren JC; Slob W
    Crit Rev Toxicol; 2009; 39(5):418-26. PubMed ID: 19514914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpreting plots of a multidimensional dose-response surface in a parallel coordinate system.
    Gennings C; Dawson KS; Carter WH; Myers RH
    Biometrics; 1990 Sep; 46(3):719-35. PubMed ID: 2242411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adverse effects and safety of antimicrobial agents--drug interactions].
    Sawada Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():609-14. PubMed ID: 17455690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.